Yi Wei
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Liver-kidney crosstalk in primary biliary cholangitis: insights into the mechanisms of renal involvement.
Journal: Frontiers in immunology
Published: April 01, 2026
Twelve-month follow-up after telitacicept withdrawal in patients with SLE: a single-centre study.
Journal: Lupus science & medicine
Published: October 19, 2025
Dose Reduction of Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients With Complete Biochemical Response: An Open-Label Randomized Clinical Trial.
Journal: Journal of gastroenterology and hepatology
Published: August 30, 2025
A BAFF/APRIL dual inhibitor for the treatment of systemic lupus erythematosus: a long-term, observational, real-world study.
Journal: Arthritis research & therapy
Published: July 08, 2025
Clinical characteristics of dyslipidemia in patients with primary biliary cholangitis: a single-center experience in China.
Journal: Clinical rheumatology
Published: March 22, 2025
Postpartum may be a risk factor for biochemical flares in patients with primary biliary cholangitis: A single-center experience.
Journal: Clinical rheumatology
Published: January 26, 2025
Revisiting PPAR agonists: novel perspectives in the treatment of primary biliary cholangitis.
Journal: Expert opinion on pharmacotherapy
Published: September 23, 2024
Animal models of primary biliary cholangitis: status and challenges.
Journal: Cell & bioscience
Published: September 14, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026